Director/PDMR Shareholding

AstraZeneca PLC 02 April 2007 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DR 3.1.2R We hereby inform you that on 30 March 2007 the following individuals, who are all persons discharging managerial responsibilities, were granted options under the AstraZeneca Share Option Plan over the Company's USD0.25 Ordinary Shares or, in the case of A Zook, over the Company's American Depositary Shares (ADSs). One ADS equals one Ordinary Share Number of shares over which Exercise price Period when exercisable Name of individual option is granted per share B Angelici 32,887 2744p 30.3.10-29.3.17 A P Bloxham 18,122 2744p 30.3.10-29.3.17 J Lundberg 22,659 2744p 30.3.10-29.3.17 M Nicklasson 29,268 2744p 30.3.10-29.3.17 D Smith 21,865 2744p 30.3.10-29.3.17 A Zook 54,423 US$53.80 30.3.10-29.3.17 The options will become exercisable on 30 March 2010 subject to certain performance conditions. The conditions, which will not be subject to any retesting, are that the earnings per share of the Company must increase by the increase in the UK Retail Prices Index plus 5% per annum on average over three years, and that no significant unforeseen event has taken place which, in the reasonable opinion of the Remuneration Committee, has resulted in major reputational damage to AstraZeneca, and the circumstances of which are exceptional enough to justify the option not vesting and becoming exercisable. Failure to satisfy either or both of these conditions will result in the lapse of the option in its entirety. G H R Musker Company Secretary 2 April 2007 This information is provided by RNS The company news service from the London Stock Exchange

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings